FinancialContent

(CSE:ADPT)

0.2900 UNCHANGED
Delayed Quote Updated: 1:23 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ADPT

Adaptogenics Health Corp. (CSE: ADPT) Targets Supply, Verification, Traceability in Emerging Peptide Market
Via Investor Brand Network
BioMedNewsBreaks — Adaptogenics Health Corp. (CSE: ADPT) Gains Industry Relevance as FDA Eases Restrictions on Pharmacy-Compounded Peptides, NBC News Reports
Via Investor Brand Network
BioMedNewsBreaks — Adaptogenics Health Corp. (CSE: ADPT) Sees Regulatory Landscape Shift as Federal Policy Permits Compounding of Six Peptides, Reuters Reports
Via Investor Brand Network
NetworkNewsBreaks – Adaptogenics Health Corp. (CSE: ADPT) Draws Sector Attention as RFK Jr. Pushes for Safer, Regulated Peptide Access, iHeartRadio Reports
Via Investor Brand Network
Topics Government
BioMedNewsBreaks — Adaptogenics Health Corp. (CSE: ADPT) in Focus as Trump Administration Advances Peptide Access Policy, AP Reports
Via Investor Brand Network
Topics Government
Why Adaptogenics Health Corp. (CSE: ADPT) Is ‘One to Watch’
Via Investor Brand Network
Topics Initial Public Offering Intellectual Property